---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-032946"
form_type: "8-K"
ticker: "PHAT"
cik: "0001783183"
company_name: "Phathom Pharmaceuticals, Inc."
filed_at: "2024-02-13T23:59:59+00:00"
generated_at: "2026-06-06T03:33:14.050587+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Express Scripts adds VOQUEZNA to national formularies for commercial plans

## Summary
- Express Scripts, a leading U.S. PBM, added VOQUEZNA to its national formularies for commercial plans, effective immediately.
- Formulary placement offers access to VOQUEZNA with a single step through a generic proton pump inhibitor (PPI).
- Expanded formulary access may drive uptake of Phathom's approved product VOQUEZNA.

## SEC filing metadata
- accession: 0001193125-24-032946
- form_type: 8-K
- ticker: PHAT
- cik: 0001783183
- company_name: Phathom Pharmaceuticals, Inc.
- filed_at: 2024-02-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1783183/000119312524032946/0001193125-24-032946-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1783183/000119312524032946/d784856d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-032946
- JSON: https://secwatch.observer/filing/0001193125-24-032946.json
- Plain text: https://secwatch.observer/filing/0001193125-24-032946.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.